Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bizzi

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Clinical Rheumatology|February 11, 2014
Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative reviewE Bizzi, U Massafra, B Laganà, et al.
Drug Design, Development and Therapy|April 15, 2017
An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritisL S Martin-Martin, F Giovannangeli, E Bizzi, et al.
European Review for Medical and Pharmacological Sciences|June 26, 2008
Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren's syndrome treated with infliximab: case reportA Migliore, A Signore, A Capuano, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|June 4, 2016
Differences among Branded Hyaluronic Acids in Italy, Part 1: Data from In Vitro and Animal Studies and Instructions for UseA Migliore, E Bizzi, O De Lucia, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Mixed panniculitis responding to cyclosporin-A with a 12-month follow-up: a case reportA Migliore, E Bizzi, C M Santacroce, et al.
European Review for Medical and Pharmacological Sciences|April 22, 2017
HyalOne® in the treatment of symptomatic hip OA - data from the ANTIAGE register: seven years of observationA Migliore, U Massafra, B Frediani, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|December 5, 1998
Group report: representations in natural and artificial systemsP König, E Bizzi, N Burgess, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|June 10, 2016
Differences Regarding Branded HA in Italy, Part 2: Data from Clinical Studies on Knee, Hip, Shoulder, Ankle, Temporomandibular Joint, Vertebral Facets, and Carpometacarpal JointA Migliore, E Bizzi, O De Lucia, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
A new chance to maintain remission induced by anti-TNF agents in rheumatoid arthritis patients: CYnAR study II of a 12-month follow-upA Migliore, E Bizzi, U Massafra, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study)A Migliore, E Bizzi, U Massafra, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Clinical Rheumatology|February 11, 2014
Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative reviewE Bizzi, U Massafra, B Laganà, et al.
Drug Design, Development and Therapy|April 15, 2017
An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritisL S Martin-Martin, F Giovannangeli, E Bizzi, et al.
European Review for Medical and Pharmacological Sciences|June 26, 2008
Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren's syndrome treated with infliximab: case reportA Migliore, A Signore, A Capuano, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|June 4, 2016
Differences among Branded Hyaluronic Acids in Italy, Part 1: Data from In Vitro and Animal Studies and Instructions for UseA Migliore, E Bizzi, O De Lucia, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Mixed panniculitis responding to cyclosporin-A with a 12-month follow-up: a case reportA Migliore, E Bizzi, C M Santacroce, et al.
European Review for Medical and Pharmacological Sciences|April 22, 2017
HyalOne® in the treatment of symptomatic hip OA - data from the ANTIAGE register: seven years of observationA Migliore, U Massafra, B Frediani, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|December 5, 1998
Group report: representations in natural and artificial systemsP König, E Bizzi, N Burgess, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|June 10, 2016
Differences Regarding Branded HA in Italy, Part 2: Data from Clinical Studies on Knee, Hip, Shoulder, Ankle, Temporomandibular Joint, Vertebral Facets, and Carpometacarpal JointA Migliore, E Bizzi, O De Lucia, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
A new chance to maintain remission induced by anti-TNF agents in rheumatoid arthritis patients: CYnAR study II of a 12-month follow-upA Migliore, E Bizzi, U Massafra, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study)A Migliore, E Bizzi, U Massafra, et al.
Pageof 9